The role of inflammation in cancer of the esophagus

KE O'Sullivan, JJ Phelan, C O'Hanlon… - Expert review of …, 2014 - Taylor & Francis
Esophageal adenocarcinoma is the eighth most common malignancy worldwide. The
overall prognosis is poor, with 5-year survival ranges of approximately 15–25%, and 30 …
被引用次数：69 相关文章
[PDF] academia.edu

[PDF][PDF] The role of inflammation in cancer of the esophagus

KE O'Sullivan, JJ Phelan, C O'Hanlon, J Lysaght… - academia.edu
Esophageal adenocarcinoma is the eighth most common malignancy worldwide. The
overall prognosis is poor, with 5-year survival ranges of approximately 15–25%, and 30 …

The role of inflammation in cancer of the esophagus

KE O'Sullivan, JJ Phelan… - Expert review of …, 2014 - pubmed.ncbi.nlm.nih.gov
Esophageal adenocarcinoma is the eighth most common malignancy worldwide. The
overall prognosis is poor, with 5-year survival ranges of approximately 15-25%, and 30-50 …

The role of inflammation in cancer of the esophagus

KE O'Sullivan, JJ Phelan, C O'Hanlon… - Expert Review of …, 2014 - search.proquest.com
Esophageal adenocarcinoma is the eighth most common malignancy worldwide. The
overall prognosis is poor, with 5-year survival ranges of approximately 15-25%, and 30-50 …

The role of inflammation in cancer of the esophagus.

KE O'Sullivan, JJ Phelan, C O'Hanlon… - Expert Review of …, 2014 - europepmc.org
Esophageal adenocarcinoma is the eighth most common malignancy worldwide. The
overall prognosis is poor, with 5-year survival ranges of approximately 15-25%, and 30-50 …
[PDF] researchgate.net

[PDF][PDF] The role of inflammation in cancer of the esophagus

KE O'Sullivan, JJ Phelan, C O'Hanlon, J Lysaght… - researchgate.net
Esophageal adenocarcinoma is the eighth most common malignancy worldwide. The
overall prognosis is poor, with 5-year survival ranges of approximately 15–25%, and 30 …